# Osteotech, Inc. – FDA Inspection, Aug 12, 2021

Source: https://www.keypedia.com/records/fda_inspections/osteotech-inc/5d361e25-cf2a-4c5e-8652-100402b95bc5
Source feed: FDA_Inspections

> FDA inspection 1150237 of Osteotech, Inc., August 12, 2021. Classification: No Action Indicated (NAI). 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1150237
- Company Name: Osteotech, Inc.
- Inspection Date: 2021-08-12
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1245789 - 2024-06-18
- [FDA Inspection 1060874 - 2018-07-30](https://www.keypedia.com/records/fda_inspections/osteotech-inc/53653e50-b1c2-439f-9985-fa3c1388351b)
- [FDA Inspection 1021037 - 2017-08-10](https://www.keypedia.com/records/fda_inspections/osteotech-inc/e4a403d7-328b-4e7c-a1de-3e59c35cb327)
- FDA Inspection 925160 - 2015-05-06
- FDA Inspection 845708 - 2013-08-16

Company: https://www.keypedia.com/companies/osteotech-inc/916ecda8-a52b-4078-aadc-eaee17461f83

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
